Global Drug Screening Market

Drug Screening Market Size, Share, Growth Analysis, By Type(Alcohol, Cannabis), By End-User(Drug testing laboratories and Workplaces) - Industry Forecast 2024-2031

Report ID: SQMIG35D2198 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 75

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Drug Screening Market size was valued at USD 5.3 billion in 2021 and is poised to grow from USD 6.22 billion in 2022 to USD 26.15 billion by 2030, growing at a CAGR of 17.3% during the forecast period (2023-2030).

Details about each company are included in the drug screening market competitive landscape. The company's financials, revenue generated, market potential, investment in R&D, new market initiatives, presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are among the details that are included. The aforementioned data points are limited to the companies' market focus on drug screening. 'LabCorp (US)', 'Quest Diagnostics (US)', 'Abbott (US)', 'Thermo Fisher Scientific, Inc. (US)', 'Alfa Scientific Designs, Inc. (US)', 'OraSure Technologies, Inc. (US)', 'Siemens (Germany)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'MPD Inc. (US)', 'Shimadzu Corporation (Japan)', 'Lifeloc Technologies, Inc. (US)', 'Drägerwerk AG & Co. KGaA (Germany)', 'Premier Biotech, Inc. (US)', 'Omega Laboratories, Inc. (US)', 'Psychemedics Corporation (US)', 'Clinical Reference Laboratory Inc., (US)', 'American Bio Medica Corporation (US)', 'ACM Laboratories (US)', 'Sciteck, Inc. (US)', 'Synens SAS (France)'

As drug screening products and services are increasingly used on the road, it is anticipated that the expanding use of illicit drugs will also hasten the market's overall expansion. Additionally, teen drug use will support market expansion. Additionally, the screening is simple to put into practise, providing flexible and successful workplace drug testing, which is also anticipated to support market expansion. One important element that is anticipated to temper the market's expansion is the rise in government spending to combat drug trafficking. Future drug screening market growth will be further accelerated by the rise in traffic accidents brought on by drugged driving and prescription medication abuse.

The drug screening market is witnessing several key market trends that are shaping its growth and trajectory. Firstly, there is a growing adoption of advanced technologies in drug screening. This includes the development of more sensitive and accurate testing methods, such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays, which enhance the detection capabilities of drug screening procedures. Another significant trend is the increasing focus on oral fluid drug testing. Saliva-based drug screening offers non-invasive sample collection and provides a convenient alternative to urine and blood tests. It has a shorter detection window but offers real-time drug use detection and is particularly valuable in post-accident and roadside testing scenarios. Overall, the key market trends in the drug screening industry revolve around advanced technologies, rapid on-site testing, oral fluid testing, expanded drug panels, and the integration of AI and ML. These trends reflect the industry's continuous efforts to enhance accuracy, convenience, and efficiency in drug screening processes.

North America dominated the Drug Screening market. The region accounts for holding the largest share revenue of over 39.1%. This can be attributed to several factors. Firstly, the region has a well-established healthcare infrastructure and stringent regulatory frameworks that promote drug testing and monitoring programs. Additionally, the high prevalence of drug abuse and addiction issues in North America has further fueled the demand for drug screening services. The region is also home to several major drug screening companies and laboratories, contributing to its dominance in the market. Furthermore, the strong presence of workplace safety initiatives and strict anti-doping measures in sports organizations has further boosted the demand for drug screening services in North America.

Related Reports

Non-small Cell Lung Cancer Therapeutics Market
Buy Now GET FREE SAMPLE
Ligament Repair and Reconstruction Market
Buy Now GET FREE SAMPLE
Advanced Wound Care Market
Buy Now GET FREE SAMPLE
Veterinary Prosthetics & Orthotics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Drug Screening Market

Product ID: SQMIG35D2198

$5,300
BUY NOW